A pharmaceutical company could fund the creation of an app to promote gambling, alcohol, unhealthy processed food, with claims that an ersatz dairy spread can reduce cholesterol and the risk of cardiovascular disease, and missile systems. It would be entirely lawful. However, it could not lawfully promote its approved therapeutic products on the app, while virtually everyone else is free to discuss them.
This regulatory restriction is too harmful to be described as simply outdated
January 25, 2026 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Medicines Australia seeks answers on AI in HTA process
September 23, 2026 - - Latest News -
The prevention gap and inside Sally Panton's bet on cellular health
September 23, 2026 - - Latest News -
Pfizer 'deeply disappointed' in response to PBAC refusing to move on price
September 23, 2026 - - Latest News -
Lilly goes direct with a patient platform for its non-PBS medicines
September 23, 2026 - - Latest News -
A 'multistakeholder' reference group to shadow agreement negotiations
September 23, 2026 - -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News
